Expand SBFM Menu
SBFM MENU

SBFM Latest Press Releases

-- August 31, 2026 --

Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions ACCESS Newswire 9:00 AM

-- August 26, 2026 --

A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer's Biggest Opportunity Globe Newswire 9:20 AM
Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer ACCESS Newswire 9:00 AM

-- August 19, 2026 --

Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market ACCESS Newswire 9:00 AM

-- August 7, 2026 --

Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market ACCESS Newswire 9:00 AM

-- August 4, 2026 --

Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval ACCESS Newswire 9:00 AM

-- July 28, 2026 --

Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting ACCESS Newswire 8:00 AM

-- July 20, 2026 --

Sunshine Biopharma and University of Arizona Publish Significant New Research Findings ACCESS Newswire 8:30 AM

-- June 25, 2026 --

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) ACCESS Newswire 8:00 AM

-- June 1, 2026 --

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) ACCESS Newswire 8:00 AM

-- May 29, 2026 --

Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology ACCESS Newswire 8:00 AM

-- May 28, 2026 --

Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing ACCESS Newswire 9:00 AM

-- May 21, 2026 --

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin ACCESS Newswire 7:00 AM

-- May 19, 2026 --

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering ACCESS Newswire 12:08 PM

-- May 18, 2026 --

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering ACCESS Newswire 12:17 PM
Market Data Delayed 15 Minutes